In addition to achieving a synergistic effect of chemotherapy and gene therapy (21.33% apoptosis rate of cancer cells, compared to 14.32% for 5-Fu and 9.41% for p53 monotherapies), coumarins can also emit blue fluorescence, enabling the nanocarrier to function as a fluorescent probe to detect trace drugs concentrations. The gene discussed is TP53; the disease is cancer.